- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Axitinib – November 2014
Axitinib; tablets, 1 mg & 5 mg; Inlyta®
Last updated
8 March 2018